ESG investing: 3 UK shares I’d consider

Looking for shares to buy now from an ESG investing perspective, Christopher Ruane weighs the investment case for three UK stocks.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

ESG investing has become more popular as investors consider the environmental, social, and governance aspects of their holdings. The idea of ESG investing may sound appealing. But in practice there is no agreed standard of what constitutes an ESG share.

Here are three shares I think have at least some ESG credentials. I consider whether I would add them to my portfolio – but only one attracts me right now.

Access to medicine leader

Well-known pharma giant GlaxoSmithKline (LSE: GSK) is often prominent on lists ranking shares by their ESG credentials. That is because of the company’s focus on broadening access to medicine. The company came top out of 20 pharma companies assessed in this year’s Access to Medicine Index. GSK’s pipeline includes drugs targeting priority diseases prevalent in poorer countries.

That may give GSK some credibility when it comes to ESG investing. But I feel the investment case for the company is more mixed. The relative weakness of its pipeline has worried analysts in recent years. The dividend of 5.6% is attractive for a FTSE 100 stalwart. But the company has indicated that it may effectively reduce the dividend after the imminent spin-off of its consumer division.

Despite improving steadily since the start of March, the GSK share price is still down 14% over the past year. That reflects investor nervousness about the strategic listlessness of the company and its pipeline. The spin-off could help bring more focus – but that isn’t guaranteed. I’m tempted by the yield, but for now am sitting out GSK to see how the spin-off goes.

ESG investing in recycling

Shares in recycling service providers are an obvious candidate for ESG investing. Should I consider buying shares in Augean (LSE: AUG), which specialises in hazardous waste management? From landfill sites to decommissioned oil rigs, Augean is involved in activities including waste treatment and recycling.

There has been talk of a possible bid for Augean. The deadline for a firm bid expired last week but has now been extended to next month. The Augean share price is up 59% in the past year. Augean shares now trade on a price-to-earnings ratio of almost 20.

I think the company has growth potential due to its specialist expertise at a time of heightening environmental standards. But after an increase following the news of a possible bid, I wouldn’t add the shares to my portfolio right now. If a bid doesn’t materialise, the shares risk returning to where they were before bid speculation emerged.

Closed loop recycling

Another company involved in recycling is paper and packaging firm D S Smith (LSE: SMDS). From an ESG investing perspective, its closed loop approach to recycling offers environmental benefits.

I also like D S Smith’s business performance and strategic focus. Last year, revenue and post-tax profits both fell due to the pandemic. But demand for packaging has surged due to an increase in online shopping. With its well-established operations in Europe and North America, D S Smith should benefit from that. The demand surge also poses a risk, though, as material prices have moved sharply up – something the company flagged in its results last week. That could hurt profit margins.

But with its proven ability to profit from paper and packaging, I would consider buying D S Smith for my portfolio.

Christopher Ruane has no shares in any company mentioned. The Motley Fool UK has recommended DS Smith and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Will Lloyds shares rise 25% or 39% by this time next year?

Lloyds shares are expected to rebound after sinking to fresh multi-month peaks. Royston Wild considers the outlook for the FTSE…

Read more »

Modern suburban family houses with car on driveway
Investing Articles

£7,500 invested in Taylor Wimpey shares 18 months ago is now worth…

A raft of issues have been plaguing the housebuilding sector in the last year-and-a-half. How bad was the damage for…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

£210 drip-fed into this 6.8%-yielding UK stock could lead to a £1,000 second income 

This FTSE 100 dividend stock has slumped nearly 11% inside two weeks, making it a worthy candidate to consider for…

Read more »

ISA Individual Savings Account
Investing Articles

ISA or SIPP? 2 factors to consider

As next month's ISA contribution deadline creeps up, our writer considers a couple of key differences between using a SIPP,…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is this 5.6% yielding dividend share a brilliant defensive bolthole as war rages?

Harvey Jones looks at a FTSE 100 dividend share with a brilliant record of delivering income and growth, and wonders…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

2 quality UK stocks trading below intrinsic value?

UK stocks have a reputation for being cheap, but could value investors be in dreamland with the opportunities being presented…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

£15,000 put into Greggs shares a year ago is worth this much now…

Greggs' sausage rolls may be tasty enough -- but its shares have left a bad taste in some investors' mouths…

Read more »

Investing Articles

FTSE 100 drops sharply — are serious bargains emerging in UK stocks?

Andrew Mackie looks at the FTSE 100 and explores how sharp falls, market volatility, and structural opportunities are reshaping the…

Read more »